Related Experiment Video
Updated: Jul 24, 2025
04:38
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
15.7K
Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis
Abigail Medford1, Jonathan Childs1, Ashleigh Little1
1Department of Medical Physiology, Texas A&M University School of Medicine, Bryan, TX, USA.
Journal of Clinical and Translational Hepatology
|July 6, 2023
Summary
Primary biliary cholangitis (PBC) is an autoimmune liver disease with no cure. Ursodeoxycholic acid (UDCA) helps reduce injury, with other therapies managing symptoms and progression toward liver transplantation.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease affecting intrahepatic bile ducts.
- It involves a loss of immune tolerance to mitochondrial antigens.
- Currently, no definitive cure exists for PBC.
Purpose of the Study:
- To review the pathogenesis of primary biliary cholangitis.
- To discuss current therapeutic strategies for managing PBC.
- To highlight the role of ursodeoxycholic acid (UDCA) and other treatments.
Main Methods:
- This is a review article.
- Literature search on PBC pathogenesis and treatment.
- Synthesis of current knowledge on PBC management.
Main Results:
- Ursodeoxycholic acid (UDCA) is the first-line treatment, reducing liver injury.
- Additional therapies can be used with or instead of UDCA to manage symptoms and slow progression.
- Liver transplantation remains the only potentially curative option for end-stage disease.
Conclusions:
- Understanding PBC pathogenesis is crucial for developing effective treatments.
- Current therapies focus on managing symptoms and slowing disease progression.
- Liver transplantation is reserved for advanced cases.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
115
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
115
01:29Inflammatory Bowel Disease IV: Pharmacological Management
155
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
155
01:17Chronic Bowel Disorders: Introduction
489
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489
01:26Peptic Ulcer Disease IV: Management
113
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
113
01:30Acute Pancreatitis II: Clinical Manifestations and Management
150
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
150
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K